Skip to main content

UBS Group AG

Position in ONC — BeOne Medicines Ltd.

CIK 1610520 ZURICH, V8

Position in ONC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$73,690,106
-$49,650,443 QoQ
Shares Held
258,589
-37.7% QoQ
Ownership
0.229%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#19
of 282 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 93% Shared 0% None 7%

Common Shares in ONC Over Time

Shares Held

Position Value (USD)

Derivatives in ONC

reported options exposure · as of Jun 30, 2023
CallValue
$0
CallShares
0
PutValue
$16,710,276
PutShares
93,720

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,180 across 562 Biotechnology names. ONC ranks #28 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ONC

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $73,690,106 258,589
2026-03-31 $123,340,549 415,330
2025-12-31 $46,205,551 152,087
2025-09-30 $35,744,539 104,915
2025-06-30 $43,939,334 181,515
2025-03-31 $17,718,538 65,101
2024-12-31 $16,895,052 91,468
2024-09-30 $8,020,394 35,724
2024-06-30 $1,724,307 12,086
2024-03-31 $4,480,102 28,647
2023-12-31 $1,354,683 7,511
2023-09-30 $4,909,909 27,297
2023-06-30 $16,710,276 93,720
2023-06-30 $16,078,024 90,174
2023-03-31 $7,793,132 36,158
2022-12-31 $1,302,923 5,924
2022-09-30 $7,061,062 52,374
2022-06-30 $2,810,847 17,367
2022-03-31 $15,950,278 84,572
2021-12-31 $12,035,793 44,424
2021-09-30 $31,427,814 86,578
2021-06-30 $17,070,613 49,741
2021-03-31 $16,248,722 46,681
2020-12-31 $22,442,721 86,856
2020-09-30 $7,675,732 26,797
2020-06-30 $8,063,519 42,800
2020-03-31 $5,190,562 42,162